Kura Oncology to partner with Japan’s Kyowa Kirin for blood cancer therapy

Kura Oncology and Kyowa Kirin have announced a collaboration to develop and commercialize the blood cancer therapy ziftomenib. Kura will lead the development of the drug for acute myeloid leukemia, with potential for treating other blood cancers. The companies will share profits and losses, with Kura receiving an upfront payment of $330 million and up […]